Šalis: Australija
kalba: anglų
Šaltinis: Department of Health (Therapeutic Goods Administration)
olanzapine, Quantity: 2.5 mg
Amneal Pharma Australia Pty Ltd
Olanzapine
Tablet, uncoated
Excipient Ingredients: lactose monohydrate; magnesium stearate; crospovidone; hyprolose
Oral
30
(S4) Prescription Only Medicine
Olanzapine is indicated for the treatment of schizophrenia and related psychoses. ,Olanzapine alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. ,Olanzapine is indicated for preventing recurrence of manic, mixed or depressive episodes in Bipolar I Disorder.
Visual Identification: Yellow coloured, circular, biconvex uncoated tablets, debossed with "C" on one side and "45" on the other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 18 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2011-11-15